Amber Tong

Researchers have been working for decades on so-called brain-computer interfaces to help people who suffer from paralysis, blindness, hearing loss, and more, regain function.

Hangzhou Sciwind Biosciences Co. is in “deep discussions” to expand its weight-loss drug beyond China, buoyed by new clinical data that shows the therapy helped patients lose more weight than Novo Nordisk A/S’s Wegovy.

The brain has emerged as a new frontier in medical technology. Bloomberg Primer explores where the next neurotechnology advances will lead.

The designation could threaten a key revenue stream for the drug contractor and complicate research, manufacturing and supply chains for American pharmaceutical firms.

AstraZeneca Plc will pay China’s Dizal Jiangsu Pharmaceutical Co. $600 million upfront for global rights to a lung cancer drug, adding a commercial-ready treatment to its franchise amid a wave of deals from China.

President Donald Trump’s threat of 100% tariffs against generic medicines is a major expansion of a strategy he’s been using against the pharmaceutical industry since his second term began.

Generic drug tariffs could send prices soaring for millions of Americans

A young girl died after receiving an experimental gene-editing treatment in a clinical trial in Shanghai, Science reported, raising questions about regulatory oversight and transparency as China rapidly expands its biotechnology ambitions.

WuXi AppTec Co Ltd said its inclusion on the Pentagon’s list of companies allegedly tied to the Chinese military is damaging its reputation and injecting uncertainty into its critical US business, as it continues to challenge the designation.

Prices of lab monkeys in China have surged, complicating new drug development trials and increasing the need for primate imports from neighboring countries.